Bio Impact Capital LLC Xeris Biopharma Holdings, Inc. Transaction History
Bio Impact Capital LLC
- $611 Million
- Q1 2024
A detailed history of Bio Impact Capital LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 4,166,496 shares of XERS stock, worth $9.37 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
4,166,496
Previous 3,847,232
8.3%
Holding current value
$9.37 Million
Previous $9.04 Million
1.85%
% of portfolio
1.51%
Previous 2.2%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
57.3MCall Options Held
87.6KPut Options Held
80.4K-
Black Rock Inc. New York, NY9.96MShares$22.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.61MShares$17.1 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$11.5 Million69.8% of portfolio
-
State Street Corp Boston, MA3.22MShares$7.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.05MShares$6.85 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $306M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...